Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer

Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study

Sepesi, B; Cascone, T; William, W; Lin, H; Leung, C; Weissferdt, A; Walsh, G; Rice, D; Roth, J; Mehran, R; Hofstetter, W; Antonoff, M; Fossella, F; Mott, F; Le, X; Skoulidis, F; Zhang, J; Byers, L; Lam, V; Glisson, B; Kurie, J; Blumenschein, G; Tsao,